| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.07 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.08 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.075 | 0.08 |